[{"data":1,"prerenderedAt":415},["ShallowReactive",2],{"slug-big-pharma-part-one":3},{"post":4,"relatedPosts":169,"relatedBooks":322},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":33,"project_category":42,"contact_email_category":44,"yst_prominent_words":45,"class_list":54,"better_featured_image":72,"acf":104,"yoast_meta":113,"_links":116},36507,"2021-10-12T10:00:00","2021-10-12T08:00:00",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=36507&#038;_wpnonce=a0cbf10c00&#038;status=auto-draft&#038;type=post","2021-10-12T18:34:11","2021-10-12T16:34:11","big-pharma-part-one","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one",{"rendered":17},"Big Pharma, Big Money: Johnson&#038;Johnson, Pfizer, Bayer, Novartis in digital health",{"rendered":19,"protected":20},"\n\u003Cp>In \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Ftech-giants-in-healthcare-2021-summary\" target=\"_blank\">a recent series of articles\u003C\u002Fa>, we explored the latest moves of Tech Giants like \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Famazons-march-into-healthcare-a-2021-update\" target=\"_blank\">Amazon\u003C\u002Fa>, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fnvidia-in-healthcare-2021\" target=\"_blank\">NVIDIA\u003C\u002Fa> and \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmicrosoft-in-healthcare-2021\" target=\"_blank\">Microsoft\u003C\u002Fa> in the field of digital health. Analysing these recent developments can give us a better idea regarding where they are focusing the efforts, and how it might shape the future path of healthcare.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>But equally, if not more, strong players in this field are pharmaceutical giants, as their resources and influence can significantly shape or alter the course of this path.\u003C\u002Fstrong> As such, we are kickstarting a new series of articles focusing on the digital health efforts of 14 global pharma companies. While those heavyweights are involved in a plethora of healthcare-related projects from vaccine development to clinical trials, we will specifically focus on digital health.\u003C\u002Fp>\n\n\n\n\u003Cp>In the first article to the series, we will explore developments coming from pharma giants Johnson &amp; Johnson, Pfizer, Bayer and Novartis. Let’s take a closer look!\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Johnson &amp; Johnson: consumer-facing\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>While Johnson &amp; Johnson (J&amp;J) has been involved in the healthcare industry for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fiercehealthcare.com\u002Ftech\u002Fwhy-johnson-johnson-investing-a-telehealth-startup\" target=\"_blank\">over a century\u003C\u002Fa>, these days the brand is most likely associated with \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.jnj.com\u002Fjohnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic\" target=\"_blank\">the single-shot COVID-19 vaccine\u003C\u002Fa>. But its pandemic efforts extend beyond the vaccine as well.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cp>In early 2020, the company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.prnewswire.com\u002Fnews-releases\u002Fprisma-health-collaborates-with-ethicon-inc-part-of-the-johnson--johnson-medical-devices-companies-to-manufacture-and-distribute-the-vesper-ventilator-expansion-splitter-device-that-is-authorized-for-emergency-use-only-during-301035945.html\" target=\"_blank\">partnered with Prisma Health\u003C\u002Fa> for the manufacturing and distribution of the VESper Ventilator Expansion Splitter, a ventilator expansion device. A single ventilator fitted with it can provide ventilatory support for two rescuable patients until individual ventilators are available.\u003C\u002Fp>\n\n\n\n\u003Cp>J&amp;J also explored other digital health technologies that proved to be valuable during the crisis. It \u003Ca href=\"https:\u002F\u002Fwww.jnj.com\u002Finnovation\u002F4-ways-johnson-johnson-advanced-healthcare-amid-the-pandemic\" target=\"_blank\" rel=\"noreferrer noopener\">collaborated with Koa Health\u003C\u002Fa> to research the use of digital cognitive behavioral therapy for treatment-resistant major depressive disorder.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cp>Another pandemic-ready technology that the pharmaceutical giant showed interest in is telemedicine. In Q3 2020, the company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fiercehealthcare.com\u002Ftech\u002Fwhy-johnson-johnson-investing-a-telehealth-startup\" target=\"_blank\">announced that it is investing\u003C\u002Fa> in direct-to-consumer telehealth company Thirty Madison. The latter focuses on conditions like hair loss and acid reflux, whose treatments are sold by J&amp;J itself.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"260\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid-768x260.jpg\" alt=\"\" class=\"wp-image-36509\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid-768x260.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid.jpg 1534w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.jnj.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Still on the topic of consumer-oriented digital health tools, the pharma giant \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.jnj.com\u002Fjohnson-johnson-launches-heartline-the-first-of-its-kind-virtual-study-designed-to-explore-if-a-new-iphone-app-and-apple-watch-can-help-reduce-the-risk-of-stroke\" target=\"_blank\">announced its partnership with Apple\u003C\u002Fa> in February 2020. The collaboration involves a study using the Apple Watch to determine whether the device can detect atrial fibrillation earlier so as to reduce the risk of developing stroke and improve health outcomes. Paul Burton, J&amp;J’s vice president of medical affairs, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.cnbc.com\u002F2020\u002F02\u002F25\u002Fapple-johnson-johnson-heart-study-is-a-big-deal-for-digital-health.html\" target=\"_blank\">even told CNBC\u003C\u002Fa> that this study “\u003Cem>represents the largest randomized trial in the history of cardiovascular disease\u003C\u002Fem>.”\u003C\u002Fp>\n\n\n\n\u003Cp>J&amp;J also made moves in the clinical sphere with its surgical robotic platform \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.massdevice.com\u002Fbreaking-johnson-johnson-finally-unveils-its-new-robot-assisted-surgery-system\u002F\" target=\"_blank\">announced last November\u003C\u002Fa>. Designed with six arms and integrated into the operating table, this new system aims to provide better control and flexibility to surgeons.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Pfizer: eyeing digital therapeutics\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Pfizer is another pharma giant whose name is closely attached to a COVID-19 vaccine; but like its competitor J&amp;J, it has also been venturing into the field of digital health. More specifically, it seems to have grown some interests in the emerging \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\" target=\"_blank\">digital therapeutics (DTx) solutions\u003C\u002Fa>. In mid-2020, the company, in collaboration with SidekickHealth, \u003Ca rel=\"noreferrer noopener\" href=\"http:\u002F\u002Fwww.pharmatimes.com\u002Fnews\u002Fpfizer_links_with_sidekickhealth_for_digital_health_solution_1343312\" target=\"_blank\">launched a new digital therapeutics platform\u003C\u002Fa>. It aims to help patients with ailments like inflammatory bowel disease and arthritis gain more control over managing their condition and improve their wellbeing.\u003C\u002Fp>\n\n\n\n\u003Cp>Pfizer announced another similar collaboration in April 2021 \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Ffinance.yahoo.com\u002Fnews\u002Fpfizer-collaborates-doctoroncall-improve-health-033200173.html\" target=\"_blank\">with DoctorOnCall\u003C\u002Fa> in Malaysia. For its part, this DTx platform will focus on the three therapeutic areas of&nbsp;smoking cessation, vaccination and cardiovascular health.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png\" alt=\"\" class=\"wp-image-36065\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>In late 2020, the pharma giant, along with some other companies, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fhitconsultant.net\u002F2020\u002F12\u002F29\u002Famazon-astrazeneca-pfizer-innovation-lab-israel\u002F#.YVGaKLgzaUk\" target=\"_blank\">was selected by the Israel Innovation Authority\u003C\u002Fa> to work on an innovation lab project in the fields of digital health and computational biology. The lab aims to support startups working on A.I.-based tools for personalised treatments.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Bayer: partnerships and investments\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>German pharma company Bayer is no stranger to digital health. In 2018, it partnered with appliedVR and Samsung Health to \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-pain-reduction-kit-against-chronic-pain\u002F\" target=\"_blank\">develop digital pain reduction kits\u003C\u002Fa> using virtual reality technology. Its digital health endeavours have not waned in following years.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"712\" height=\"401\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma.jpg\" alt=\"\" class=\"wp-image-36511\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma.jpg 712w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma-370x208.jpg 370w\" sizes=\"auto, (max-width: 712px) 100vw, 712px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.mobihealthnews.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>In early 2020, Bayer \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fexscientia-lands-multi-million-euro-deal-bayer\" target=\"_blank\" rel=\"noreferrer noopener\">entered a three-year partnership\u003C\u002Fa> with British biotech firm Exscientia. The focus will be on using artificial intelligence in drug discovery in the fields of cardiology and oncology. Later that year, the pharma giant \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fbayer-looks-digital-partnerships-expand-efforts-cardiometabolic-care-oncology-and-womens-health\" target=\"_blank\" rel=\"noreferrer noopener\">launched its G4A Digital Health Partnership Program\u003C\u002Fa>. Through the latter, it will support both early-stage and experienced companies to develop digital health tools.\u003C\u002Fp>\n\n\n\n\u003Cp>Prior to this initiative, Bayer also invested in other digital health startups. For instance, in August 2020, they \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fbayers-equity-investment-development-commitments-bring-nearly-100m-one-drop\" target=\"_blank\">invested in One Drop\u003C\u002Fa>, the maker of a data-driven blood glucose monitor system. With this new round of funding, this startup will expand its expertise in other areas like cardiology, oncology and women&#8217;s health.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cp>In June 2021, the German company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedcitynews.com\u002F2021\u002F06\u002Fbayers-investment-arm-leads-digital-health-startups-90m-round\u002F\" target=\"_blank\">invested in yet another digital health startup\u003C\u002Fa>: Ada Health. The latter is known for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-big-symptom-checker-review\u002F\" target=\"_blank\">its A.I.-based symptom checker\u003C\u002Fa>. Through this investment, the two companies also plan a broader strategic partnership.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Novartis: juggling between projects and failures\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>“Embracing digital and data is a top priority for Novartis,” the company’s chief medical officer John Tsai \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fhow-novartis-embracing-digital-and-data-revolution\">once said\u003C\u002Fa>. The Swiss pharma giant has been walking that talk in recent years; even after its ill-fated partnership with Google to develop blood glucose level-sensing contact lenses that \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-future-of-diabetes-management-8-reasons-why-we-face-extraordinary-times\">didn’t amount to a viable product\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>In late 2019, it teamed up with another Big Tech company, Microsoft, \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnorth-america\u002Fnovartis-taps-microsoft-new-ai-initiative-drug-discovery-development\">on an initiative\u003C\u002Fa> to use A.I. for drug discovery and development. More recently, the Swiss pharma giant partnered with a number of digital health startups. Last November, they \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-teams-smartpatient-new-tool-patients-wet-macular-degeneration\">teamed up with smartpatient and the MyTherapy app\u003C\u002Fa> for a new feature to provide personalised educational material for wet macular degeneration patients and their caregivers.&nbsp;&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cp>In April, it \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fkaiku-health-joins-forces-novartis-melanoma-monitoring-and-support\">partnered with Kaiku Health\u003C\u002Fa> on a tool to assist in the remote monitoring and support network of melanoma patients. The following month, in May, it announced \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fada-health-partners-novartis-work-diagnosis-immunological-diseases\">a collaboration with Ada Health\u003C\u002Fa> to help improve the diagnosis for patients with immunological diseases and rare conditions.\u003C\u002Fp>\n\n\n\n\u003Cp>Novartis not only partnered with startups but also acquired one. In 2020, they \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-acquires-digital-therapeutic-using-video-games-3d-glasses-treat-lazy-eye\">acquired Amblyotech\u003C\u002Fa>, which develops a solution to treat amblyopia, or “lazy eye”, by combining a gaming software and 3D glasses. \u003C\u002Fp>\n\n\n\n\u003Cp>Like Pfizer, Novartis also expressed interest in DTx, but not with such a promising outlook. The pharma giant \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-trial-shows-no-benefits-pears-schizophrenia-app-ceo-cites-trial-irregularities\">published results of its clinical trial\u003C\u002Fa> with Pear Therapeutics&#8217; new digital therapeutic for schizophrenia in January. It didn’t find benefits from the app but Pear Therapeutics said there were &#8220;methodological issues&#8221; that were omitted in Novartis&#8217;s publication.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"403\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx-768x403.jpg\" alt=\"\" class=\"wp-image-36513\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx-768x403.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.mobihealthnews.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>From this list, we can see that the pharma companies whose moves we’ve contemplated seem to have some interest in remote healthcare solutions and DTx. They are also actively partnering with startups and tech giants so as to maximise their chances of staying relevant in the ever-evolving digital health world. In the next articles in this series, we will analyse how, and if, the approach of other pharma giants differ. Be sure to keep an eye out for those!\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó &amp; Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you&#8217;d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp>&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n",false,{"rendered":22,"protected":20},"\u003Cp>In a recent series of articles, we explored the latest moves of Tech Giants like Amazon, NVIDIA and Microsoft in the field of digital health. [&hellip;]\u003C\u002Fp>\n",16,36565,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32],521,490,[34,35,36,37,38,39,40,41],336,356,6365,7001,7385,7387,7389,207,[43],947,[],[46,47,48,49,50,51,52,53],1883,2163,4363,1571,1609,1611,1617,1681,[55,14,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71],"post-36507","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-future-medicine","category-future-of-pharma","tag-novartis","tag-pharma-2","tag-pfizer","tag-jj","tag-big-pharma","tag-johnsonjohnson","tag-bayer","tag-digital-health","project_category-company",{"id":24,"alt_text":27,"caption":27,"description":73,"media_type":74,"media_details":75,"post":5,"source_url":103}," Big Pharma, Big Money: J&J, Pfizer, Bayer, Novartis in digital health","image",{"width":76,"height":77,"file":78,"sizes":79,"image_meta":101},1920,1080,"2021\u002F10\u002Ftmf_article_295-01.png",{"medium":80,"large":86,"thumbnail":91,"medium_large":95,"1536x1536":96},{"file":81,"width":82,"height":83,"mime-type":84,"source_url":85},"tmf_article_295-01-370x208.png","370","208","image\u002Fpng","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-370x208.png",{"file":87,"width":88,"height":89,"mime-type":84,"source_url":90},"tmf_article_295-01-768x432.png","768","432","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-768x432.png",{"file":92,"width":93,"height":93,"mime-type":84,"source_url":94},"tmf_article_295-01-150x150.png","150","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-150x150.png",{"file":87,"width":88,"height":89,"mime-type":84,"source_url":90},{"file":97,"width":98,"height":99,"mime-type":84,"source_url":100},"tmf_article_295-01-1536x864.png","1536","864","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-1536x864.png",{"aperture":102,"credit":27,"camera":27,"caption":27,"created_timestamp":102,"copyright":27,"focal_length":102,"iso":102,"shutter_speed":102,"title":27,"orientation":102},"0","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01.png",{"cta_type":105,"cta_color":27,"subtitle":27,"related_books":106,"related_posts_footer":109,"related_posts":20},"subscribe",[107,108],24764,31417,[110,111,112],15585,17427,35983,{"yoast_wpseo_title":114,"yoast_wpseo_metadesc":115,"yoast_wpseo_canonical":15},"Big Pharma, Big Money: Johnson&Johnson, Pfizer, Bayer, Novartis in digital health - The Medical Futurist","Big pharma: a new series of articles by The Medical Futurist, focusing on the digital health efforts of the biggest pharma companies around the globe",{"self":117,"collection":123,"about":126,"author":129,"replies":132,"version-history":135,"predecessor-version":139,"wp:featuredmedia":143,"wp:attachment":146,"wp:term":149,"curies":165},[118],{"href":119,"targetHints":120},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507",{"allow":121},[122],"GET",[124],{"href":125},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[127],{"href":128},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[130],{"embeddable":26,"href":131},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[133],{"embeddable":26,"href":134},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=36507",[136],{"count":137,"href":138},15,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507\u002Frevisions",[140],{"id":141,"href":142},36561,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507\u002Frevisions\u002F36561",[144],{"embeddable":26,"href":145},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36565",[147],{"href":148},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=36507",[150,153,156,159,162],{"taxonomy":151,"embeddable":26,"href":152},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=36507",{"taxonomy":154,"embeddable":26,"href":155},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=36507",{"taxonomy":157,"embeddable":26,"href":158},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=36507",{"taxonomy":160,"embeddable":26,"href":161},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=36507",{"taxonomy":163,"embeddable":26,"href":164},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=36507",[166],{"name":167,"href":168,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[170],{"id":112,"date":171,"date_gmt":172,"guid":173,"modified":175,"modified_gmt":176,"slug":177,"status":13,"type":14,"link":178,"title":179,"content":181,"excerpt":183,"author":23,"featured_media":185,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":186,"categories":187,"tags":194,"project_category":209,"contact_email_category":215,"yst_prominent_words":216,"class_list":219,"better_featured_image":246,"acf":272,"yoast_meta":278,"_links":281},"2021-09-14T10:00:00","2021-09-14T08:00:00",{"rendered":174},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=35983&#038;_wpnonce=d83fdd0344&#038;status=auto-draft&#038;type=post","2021-09-26T18:06:34","2021-09-26T16:06:34","what-are-digital-therapeutics","https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics",{"rendered":180},"The Future of Digital Therapeutics: Prescribing Apps Or Sensors A Reality?",{"rendered":182,"protected":20},"\n\u003Cp>\u003Cstrong>Digital health, digital pills, digital therapeutics… With the ‘digital’ suffix being increasingly used in the digital health industry, the meaning behind some terms might not be so evident at a glance. For instance, one might think that ‘digital therapeutics’ and ‘digital pills’ are interchangeable terms; but they are in fact totally different digital health tools.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>While we \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-present-and-future-of-digital-pills\u002F\" target=\"_blank\">discussed digital pills in depth\u003C\u002Fa> last year, we have yet to talk about digital therapeutics. And this is exactly what we have set out to do with this article; as the latter might very well be a viable option in your future treatment.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>What is digital therapeutics\u003C\u002Fstrong>?\u003C\u002Fh2>\n\n\n\n\u003Cp>The \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002F\" target=\"_blank\">Digital Therapeutics Alliance\u003C\u002Fa>, a non-profit engaged in the evidence-driven advancement of digital therapeutics, even considers the term as a “new category of medicine”.&nbsp;The organisation \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Funderstanding-dtx\u002F\" target=\"_blank\">further explains that\u003C\u002Fa> \u003Cstrong>digital therapeutics (DTx) “\u003Cem>deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders\u003C\u002Fem>.”\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"562\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-app-edited.jpg\" alt=\"\" class=\"wp-image-36063\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-app-edited.jpg 1000w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-app-edited-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-app-edited-768x432.jpg 768w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.htworld.co.uk\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Particularly important in this definition is that digital therapeutics are evidence-based, clinically evaluated software. This demarcates them from \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-present-and-future-of-digital-pills\u002F\" target=\"_blank\">digital pills\u003C\u002Fa>, which are themselves physical, ingestible medications (i.e. hardware) with embedded electronic circuits.\u003C\u002Fp>\n\n\n\n\u003Cp>However, while DTx are software-based, they are subject to the same regulatory oversight that traditional medicines undergo. This ensures that the product is safe to use, effective as well as has clinical impact. They can also be prescribed independently or in concert with other medications or treatments in order to optimise patient outcomes.\u003C\u002Fp>\n\n\n\n\u003Cp>The edge of such clinically proven software is manifold. Since DTx are accessible via devices like a smartphone or tablet, they can expand access to care in underserved areas. Moreover, such a mode of care delivery, which can easily be adopted at home, forgoes any stigma tied to traditional therapies. But as with traditional medicines, the end goal of DTx is for the treatment, management or prevention of medical conditions.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Finding digital therapeutics\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Digital therapeutics are not at a conceptual stage but are well within the production and delivery stages. In fact, DTx targeting chronic medical and mental conditions have been developed \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.psychiatrictimes.com\u002Fview\u002Ffrom-theory-to-real-world-practice-clinical-integration-of-digital-therapeutics\" target=\"_blank\">over the past 15 to 20 years\u003C\u002Fa>. The Digital Therapeutics Alliance even has \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Funderstanding-dtx\u002Fproduct-library\u002F\" target=\"_blank\">a product library of DTx\u003C\u002Fa>. This list can prove to be particularly important as it helps differentiate DTx that physicians can actually prescribe from unregulated apps that overpopulate online app stores.\u003C\u002Fp>\n\n\n\n\u003Cp>To help separate the wheat from the chaff, the Digital Therapeutics Alliance has put forth \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Fwp-content\u002Fuploads\u002F2021\u002F01\u002FDTA_DTx-Definition-and-Core-Principles.pdf\" target=\"_blank\">a list of ten core principles\u003C\u002Fa> for DTx. The organisation says that all products claiming to be digital therapeutic must adhere to these foundational principles:\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"308\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-core-principles-768x308.jpg\" alt=\"\" class=\"wp-image-35987\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-core-principles-768x308.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fdigital-therapeutics-core-principles.jpg 1118w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fdtxalliance.org\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>One such DTx product is \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Fproductinsulia\u002F\" target=\"_blank\">Insula\u003C\u002Fa>, a prescription-only software that assists type 2 diabetics to manage their condition. It recommends patients personalised insulin doses as well as acts as a coach in managing their diabetes. A \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Fproductinsulia\u002F\" target=\"_blank\">randomised trial conducted in France\u003C\u002Fa> showed that a precursor to the software helped improve glucose control as compared with standard care.\u003C\u002Fp>\n\n\n\n\u003Cp>Another example of DTx is \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Fkaiku\u002F\" target=\"_blank\">Kaiku Health\u003C\u002Fa>. The app supports cancer patients by allowing them to report potential symptoms that they might encounter; subsequently, it shares self-care instructions with them. Through Kaiku Health, patients can also message their care team. Studies \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdtxalliance.org\u002Fkaiku\u002F\" target=\"_blank\">have shown that\u003C\u002Fa> such forms of digital monitoring lead to good patient adherence and satisfaction, as well as save time by reducing in-person visits or even phone consultations.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Contemplating digital concerns\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Of course, given how DTx are wholly digital options, they carry with them \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fyour-privacy-in-the-digital-health-era-the-medical-futurists-guide\u002F\" target=\"_blank\">the plethora of relevant privacy and security issues\u003C\u002Fa>. These technologies will increasingly manipulate sensitive data and will become prey to malicious third parties. As such, their design and clinical applications must factor in these issues and reinforce cybersecurity measures.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk-768x432.jpg\" alt=\"Health Insurance\" class=\"wp-image-16535\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk-512x288.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk-444x250.jpg 444w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2017\u002F10\u002Fhealth-data-at-risk.jpg 870w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fhbr.org\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Another potential issue that \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.psychiatrictimes.com\u002Fview\u002Ffrom-theory-to-real-world-practice-clinical-integration-of-digital-therapeutics\" target=\"_blank\">researchers are pointing out\u003C\u002Fa> in regards to DTx is that of “app burnout”; or the lack of adherence to prescribed DTx. While their short-term use \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.psychiatrictimes.com\u002Fview\u002Ffrom-theory-to-real-world-practice-clinical-integration-of-digital-therapeutics\" target=\"_blank\">seems to be a promising option\u003C\u002Fa> in managing chronic conditions, adherence regarding their longer-term use has yet to be explored.\u003C\u002Fp>\n\n\n\n\u003Cp>Such pertinent issues relating to DTx have to be appropriately addressed as they become viable alternatives for patients.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Will you be prescribed digital therapeutics?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>These definitions, examples and relevant concerns give a clearer picture of what digital therapeutics are. Essentially, they represent a paradigm shift in how we think of medical care delivery. While we still think that \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-health\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">digital health is a cultural transformation\u003C\u002Fa> initiated but not driven by advanced technologies, DTx will have an enormous impact on how we deliver care and practice medicine.\u003C\u002Fp>\n\n\n\n\u003Cp>Sure they might not currently be as widespread options as traditional therapies; but researchers already \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.psychiatrictimes.com\u002Fview\u002Fthe-expanding-role-of-digital-therapeutics-in-mental-health\" target=\"_blank\">expect them to increasingly have an important role\u003C\u002Fa> to play in mental health management. And we can also expect this role to extend in other medical fields as well. As such digital-based tools and programs gain more backing from clinical tests, they will be seen as viable alternatives for practitioners, who can turn their use into common practice.&nbsp;\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Cp>\u003Cstrong>Just like physicians have been prescribing lifestyle changes for appropriate ailments for centuries, they will similarly prescribe smartphone apps and digital health technologies. And this shift towards DTx will not be because they look exciting, but because they have been proven to be working for patients.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó &amp; Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you&#8217;d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp>&nbsp;\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n",{"rendered":184,"protected":20},"\u003Cp>Digital health, digital pills, digital therapeutics… With the ‘digital’ suffix being increasingly used in the digital health industry, the meaning behind some terms might not [&hellip;]\u003C\u002Fp>\n",36065,{"_acf_changed":20,"footnotes":27},[188,189,190,31,32,191,192,193],6261,504,798,516,799,494,[195,196,197,198,199,200,201,202,41,203,204,205,206,207,208],7343,759,1450,7345,760,7347,206,7349,7351,7339,1184,7341,690,1433,[210,211,212,213,214],948,950,951,952,953,[],[49,52,53,217,46,218],1723,4967,[220,14,56,57,58,59,60,221,222,223,61,62,224,225,226,227,228,229,230,231,232,233,234,70,235,236,237,238,239,240,241,242,243,244,245],"post-35983","category-forecast","category-artificial-intelligence","category-digital-health-research","category-medical-education","category-security-privacy","category-telemedicine","tag-smartphones","tag-apps","tag-health-management","tag-insula","tag-applications","tag-diabetics","tag-digital","tag-kaiku-health","tag-app-burnout","tag-dtx","tag-treatment","tag-digital-therapeutics","tag-cybersecurity","tag-privacy","project_category-developers","project_category-medical-professionals","project_category-patients","project_category-policy-makers","project_category-researchers",{"id":185,"alt_text":247,"caption":27,"description":248,"media_type":74,"media_details":249,"post":112,"source_url":271},"pharmacy smart watch DTx","Digital therapeutics, DTx\npharmacy smartwatch tracker",{"width":76,"height":77,"file":250,"sizes":251,"image_meta":270},"2021\u002F09\u002Ftmf_article_290-01.png",{"medium":252,"large":255,"thumbnail":258,"medium_large":261,"1536x1536":262,"2048x2048":265},{"file":253,"width":82,"height":83,"mime-type":84,"source_url":254},"tmf_article_290-01-370x208.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-370x208.png",{"file":256,"width":88,"height":89,"mime-type":84,"source_url":257},"tmf_article_290-01-768x432.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png",{"file":259,"width":93,"height":93,"mime-type":84,"source_url":260},"tmf_article_290-01-150x150.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-150x150.png",{"file":256,"width":88,"height":89,"mime-type":84,"source_url":257},{"file":263,"width":98,"height":99,"mime-type":84,"source_url":264},"tmf_article_290-01-1536x864.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-1536x864.png",{"file":266,"width":267,"height":268,"mime-type":84,"source_url":269},"tmf_article_290-01-2048x1152.png","2048","1152","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-2048x1152.png",{"aperture":102,"credit":27,"camera":27,"caption":27,"created_timestamp":102,"copyright":27,"focal_length":102,"iso":102,"shutter_speed":102,"title":27,"orientation":102},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01.png",{"cta_type":105,"cta_color":27,"subtitle":27,"related_books":273,"related_posts_footer":275,"related_posts":20},[107,274],24763,[111,276,277],13650,15834,{"yoast_wpseo_title":279,"yoast_wpseo_metadesc":280,"yoast_wpseo_canonical":178},"The Future of Digital Therapeutics: Prescribing Apps Or Sensors A Reality? - The Medical Futurist","What is digital therapeutics? In short, evidence-based, clinically evaluated software with an enormous impact on how we practice medicine.",{"self":282,"collection":287,"about":289,"author":291,"replies":293,"version-history":296,"predecessor-version":299,"wp:featuredmedia":303,"wp:attachment":306,"wp:term":309,"curies":320},[283],{"href":284,"targetHints":285},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35983",{"allow":286},[122],[288],{"href":125},[290],{"href":128},[292],{"embeddable":26,"href":131},[294],{"embeddable":26,"href":295},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=35983",[297],{"count":23,"href":298},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35983\u002Frevisions",[300],{"id":301,"href":302},36357,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35983\u002Frevisions\u002F36357",[304],{"embeddable":26,"href":305},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36065",[307],{"href":308},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=35983",[310,312,314,316,318],{"taxonomy":151,"embeddable":26,"href":311},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=35983",{"taxonomy":154,"embeddable":26,"href":313},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=35983",{"taxonomy":157,"embeddable":26,"href":315},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=35983",{"taxonomy":160,"embeddable":26,"href":317},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=35983",{"taxonomy":163,"embeddable":26,"href":319},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=35983",[321],{"name":167,"href":168,"templated":26},[323],{"id":108,"date":324,"date_gmt":325,"guid":326,"modified":328,"modified_gmt":329,"slug":330,"status":13,"type":331,"link":332,"title":333,"content":335,"excerpt":337,"author":339,"featured_media":340,"comment_status":25,"ping_status":25,"template":27,"yst_prominent_words":341,"class_list":342,"better_featured_image":345,"acf":365,"yoast_meta":383,"_links":386},"2020-12-02T08:54:13","2020-12-02T07:54:13",{"rendered":327},"https:\u002F\u002Fapi.medicalfuturist.com\u002F?post_type=book&#038;p=31417","2023-03-12T18:17:41","2023-03-12T17:17:41","invest-in-digital-health","book","https:\u002F\u002Fapi.medicalfuturist.com\u002Fbooks\u002Finvest-in-digital-health\u002F",{"rendered":334},"Invest In Digital Health &#8211; The Medical Futurist&#8217;s Guide",{"rendered":336,"protected":20},"\n\u003Cp>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it&#8217;s a good time to invest in Digital Health and give recommendations on where to invest by looking at the top 24 technological trends we find the most promising.\u003C\u002Fp>\n",{"rendered":338,"protected":20},"\u003Cp>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it&#8217;s a good time to invest in Digital Health and give [&hellip;]\u003C\u002Fp>\n",6,49965,[53,52,49],[343,331,344,57,59,60],"post-31417","type-book",{"id":340,"alt_text":27,"caption":27,"description":27,"media_type":74,"media_details":346,"post":108,"source_url":364},{"width":347,"height":348,"file":349,"filesize":350,"sizes":351,"image_meta":362},320,413,"2020\u002F12\u002Finvest-in-digital-health.png",69673,{"medium":352,"thumbnail":357},{"file":353,"width":347,"height":354,"mime-type":84,"filesize":355,"source_url":356},"invest-in-digital-health-320x208.png",208,31956,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health-320x208.png",{"file":358,"width":359,"height":359,"mime-type":84,"filesize":360,"source_url":361},"invest-in-digital-health-150x150.png",150,21851,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health-150x150.png",{"aperture":102,"credit":27,"camera":27,"caption":27,"created_timestamp":102,"copyright":27,"focal_length":102,"iso":102,"shutter_speed":102,"title":27,"orientation":102,"keywords":363},[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health.png",{"buy_button_text":366,"leanpub_url":367,"preview":368},"Get it on Leanpub","https:\u002F\u002Fleanpub.com\u002Fdigital-health-investments",[369,371,373,375,377,379,381],{"image":370},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-1-1.png",{"image":372},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-2.png",{"image":374},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-3.png",{"image":376},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-4.png",{"image":378},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-5.png",{"image":380},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-6.png",{"image":382},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-7.png",{"yoast_wpseo_title":384,"yoast_wpseo_metadesc":385,"yoast_wpseo_canonical":332},"Invest In Digital Health - The Medical Futurist's Guide","Investment in digital health: Digital health investment activity is robust in 2020. Read our book to learn more about investing in digital healthcare",{"self":387,"collection":392,"about":395,"author":398,"replies":401,"wp:featuredmedia":404,"wp:attachment":407,"wp:term":410,"curies":413},[388],{"href":389,"targetHints":390},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook\u002F31417",{"allow":391},[122],[393],{"href":394},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook",[396],{"href":397},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fbook",[399],{"embeddable":26,"href":400},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[402],{"embeddable":26,"href":403},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=31417",[405],{"embeddable":26,"href":406},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F49965",[408],{"href":409},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=31417",[411],{"taxonomy":163,"embeddable":26,"href":412},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=31417",[414],{"name":167,"href":168,"templated":26},1787036558327]